|
1. BIOLOGIE
|
|
|
|
1.1 BIOLOGIE - GÈNES
|
|
|
|
Major mutation pattern in cancer occurs in bursts [Wellcome Sanger Institute]
|
|
|
|
|
|
Researchers have created a huge resource for investigating the biological mechanisms that cause cancer. The scientists from the Wellcome Sanger Institute and their collaborators identified which patterns of DNA damage - mutational fingerprints that represent the origins of cancer - were present in over a thousand human cancer cell lines.
|
|
|
|
|
|
|
1.4 BIOLOGIE - TECHNOS
|
|
|
|
2.11 ETIOLOGIE - ALIMENTATION
|
|
|
|
2.6 ETIOLOGIE - ENVIRONNEMENT
|
|
|
|
4. DÉPISTAGE, DIAGNOSTIC ET PRONOSTIC
|
|
|
|
4.3 DÉP., DIAG. & PRONO. - INDUSTRIELS
|
|
|
FDA Grants Breakthrough Designation to Paige.AI [Paige]
|
|
|
|
|
|
Memorial Sloan Kettering Cancer Center began digitizing its pathology slides four years ago. Under the license agreement, Paige.AI receives de-identified images of digitized slides – more than one million such slides to date -- and is funding the digitization of an additional four million archive slides, which in total will create the largest digital pathology dataset.
|
|
|
|
|
|
|
4.5 DÉP., DIAG. & PRONO. - COLORECTAL
|
|
|
|
5.10 TRAITEMENTS - ESSAIS
|
|
|
Making Cancer Clinical Trials Available to More Patients [NCI]
|
|
|
|
|
|
Patients in clinical trials that are now following the new inclusion criteria will be more representative of the real-world patient population, thus translating into trial results that are more applicable and meaningful to patients treated in everyday practice.
|
|
|
|
|
|
|
|
5.12.10 IMMUNOTHÉRAPIES - FUSIONS ET ACQUISITIONS
|
|
|
|
5.12.2 IMMUNOTHÉRAPIES - CAR-T, THÉRAPIES CELLULAIRES
|
|
|
|
5.12.6 IMMUNOTHÉRAPIES - AMM
|
|
|
|
|
5.2 PHARMA
|
|
|
|
|
|
5.2.2 PHARMA - FUSIONS & ACQUISITIONS
|
|
|
|
5.4 TRAITEMENTS - ECONOMIE
|
|
|
A quantum of innovation and the incentives to match [STAT]
|
|
|
|
|
|
It’s unreasonable to expect regulators to perfectly fine-tune the period of exclusivity to match the value of the innovation, but neither can we say that the periods of exclusivity now doled out by the patent system and regulators are tuned just right either.
|
|
|
|
|
|
|
|
|
6. LUTTE CONTRE LES CANCERS
|
|
|
Banking on health [Nature Biotechnology]
|
|
|
|
|
|
Biomedical research and healthcare has traditionally centered on disease rather than health. Several projects gathering data on healthy people promise to change that.
|
|
|
|
|
|
|
6.10 POLITIQUES
|
|
|
|
6.10.1 POLITIQUES (USA)
|
|
|
|
6.11 PATIENTS
|
|
|
|
6.5 MÉDECINES ALTERNATIVES/COMPLÉMENTAIRES
|
|
|
|
6.8 COMMUNICATION
|
|
|